BIO, Genzyme Working With Sen. Hatch On Orphan Drug Tax Credit Refinement
Executive Summary
Legislation that would allow drug companies to begin receiving orphan drug tax credits earlier is being developed by Sen. Hatch (R-Utah) with input from the Biotechnology Industry Organization and Genzyme.
You may also be interested in...
Genzyme VP, Biotech Spokeswoman Raines Killed In D.C. Plane Crash
Genzyme VP-Government Relations Lisa Raines was among the people killed on American Airlines flight 77 when it crashed into the Pentagon in Washington, D.C. Sept. 11.
Genzyme VP, Biotech Spokeswoman Raines Killed In D.C. Plane Crash
Genzyme VP-Government Relations Lisa Raines was among the people killed on American Airlines flight 77 when it crashed into the Pentagon in Washington, D.C. Sept. 11.
Amgen Working With Sen. Kennedy On Medicare Rx Benefit Bill
Amgen is working with the ranking Democrat on the Senate Health Committee, Sen. Kennedy (D-Mass.), to develop a Medicare prescription drug benefit bill.